IRCT20200513047423N3尚未招募未知
Bioequivalance study of esomeprazol 40 mg capsules manufactured by sina pishgam daru novin pharmaceutical company on 24 healthy volunteers and comparing pharmacokinetics results with Nexium 40 capsules manufactured by AstraZeneca
Sina pishgam daru novin0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Healthy liver
- •Healthy Kidney
- •Observing BMI
排除标准
- •Out of age ranges
- •Unhealthy liver and kidney
研究者
相似试验
招募中
Unknown
Bioequivalence study of tablets of Esomeprazole 40 mgIRCT20230222057495N17Koushan Pharmed Pharmaceutical Company24
尚未招募
4 期
Bioequivalence study of esomeprazole 20 mg (Capsule vs Tablet) in healthy Thai volunteers under fasting and fed conditionsHealthy volunteersTCTR20201125002Pharmacy Service Center, Faculty of Pharmacy, Chiang Mai University89
已完成
1 期
A Study to Evaluate the Bioequivalence of Single Oral Dose of Esomeprazole Capsule and Tablet Formulation in Healthy ParticipantsHealthy ParticipantsNCT03083639Takeda52
尚未招募
不适用
Bioequivalence study of manufactured by Esmoprazole 40mg Cap. Kooshan Pharmed. Co. (Eosoflux) in Iranian healthy volunteersIRCT20200105046010N7Tabriz University of Medical Sciences24
已完成
1 期
Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult ParticipantsGastrointestinal DiseasesNCT05265247HALEON61